IDRC Digital Library

Aids Bulletin - March 2005 Vol. 14, No. 1

Show simple item record

dc.contributor.editor Rotchford Galloway, Michelle
dc.contributor.editor Stein, Joanne
dc.contributor.editor Crewe, Mary
dc.date.accessioned 2012-08-17T13:22:09Z
dc.date.available 2012-08-17T13:22:09Z
dc.date.issued 2005
dc.identifier.issn 1019-8334
dc.identifier.uri http://hdl.handle.net/10625/50121
dc.description.abstract By the end of 2004, about 11 000 of the approximately half a million people urgently needing ARVs in South Africa had access to them. The Operational Plan for comprehensive HIV/ AIDS care, management and treatment for South Africa envisaged that 153 000 people would be on ARV treatment by March 2005. This enormous shortfall is not a matter of numbers, it is a matter of lives. One of the main reasons for delays in the roll-out has been limited drug supply; such that accredited sites must continually delay treatment initiation because they cannot guarantee a steady supply of drugs to patients. This is the result of endless delays in the formal tender process at national level. Before the roll-out began, great concern was expressed about the capacity of an under-resourced public health care system to implement ARV treatment. Yet despite under-staffing and limited training opportunities, South African health care workers in ARV provision sites have proved themselves equal to the task of ARV treatment provision. And South African HIV/ AIDS patients have begun to show en mass that pessimism regarding their capacity to adhere to complicated drug regimes is unfounded. The people of South Africa, those who are affected by this epidemic and who are at the forefront of fighting it, have once again shown their mettle. And it is due to their efforts - in making the roll-out thus far a success - that any excuses as to why ARV treatment remains unavailable to the vast majority have indeed now run out. In this special issue of the AIDS Bulletin, we look at the enormous potential of the ARV roll-out for strengthening the public health sector as a whole - if the challenges involved are firstly, acknowledged and secondly, met - by all. In this regard, academics and researchers have an important role to play, not just in evaluating and monitoring the roll-out, but in contributing their skills and expertise to the development of an efficient, integrated and equitable public health care system. We are confident that this edition of the Bulletin reflects this contribution and would therefore like to thank all the authors who have contributed. We also thank Research Matters for funding this edition of the AIDS Bulletin. en
dc.format Text en
dc.format.extent 1 digital file (92 p. : ill.) en
dc.format.mimetype application/pdf
dc.language.iso en
dc.subject HIV en
dc.subject AIDS en
dc.subject SOUTH AFRICA en
dc.subject ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE en
dc.subject OPERATIONAL ACTIVITIES en
dc.subject HEALTH SYSTEM en
dc.subject RURAL URBAN DIFFERENTIALS en
dc.subject HEALTH HUMAN RESOURCES en
dc.subject HEALTH INFORMATION SYSTEM en
dc.subject PRIMARY HEALTH CARE en
dc.title Aids Bulletin - March 2005 Vol. 14, No. 1 en
dc.type Bulletin en
dc.type Journal en
idrc.project.number 102041
idrc.project.title EQUINET - Phase III en
idrc.copyright.holder Medical Research Council of South Africa
idrc.dspace.access IDRC Only en
idrc.rims.adhocgroup IDRC SUPPORTED en


Files in this item

This item appears in the following Collection(s)

Show simple item record